WOUND MANAGEMENT FORMULARY - NHS North Somerset
WOUND MANAGEMENT FORMULARY - NHS North Somerset
WOUND MANAGEMENT FORMULARY - NHS North Somerset
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Appendix Two<br />
Using Antimicrobials in Wound Care<br />
Signs of critical colonisation<br />
Delayed healing (compared with<br />
normal rate for site/condition)<br />
Wound bed deterioration increase in<br />
slough or necrosis<br />
Wound has become malodorous<br />
Increase in pain/discomfort<br />
Increase in exudate and change of<br />
colour/consistency<br />
Wound static or deteriorating<br />
The patient is not generally unwell<br />
Use first line antimicrobial for<br />
two weeks.<br />
Silvercell or Iodofex/iodosorb<br />
(mod-high exudate) Urgotul<br />
SSD (low exudates)<br />
Signs of wound infection<br />
Wound bed deterioration increase in slough<br />
and/or necrosis<br />
Increased pain.<br />
Wound has become malodorous.<br />
Increase in exudates, which can be purulent<br />
or contain blood.<br />
Friable bleeding granulation tissue.<br />
Bridging of the epithelium<br />
Pockets of pus at the base of the wound<br />
Spreading erythema<br />
Patient usually feels unwell<br />
Swab wound<br />
Commence antibiotic therapy for<br />
at least 10 days duration.<br />
Use first line antimicrobial for two<br />
weeks.<br />
Silvercell or Iodofex/iodosorb<br />
(mod-high exudates) Urgotul SSD<br />
(low exudates)<br />
Evaluate outcome of treatment<br />
Signs and symptoms<br />
resolved.<br />
Stop Antimicrobials<br />
Signs and symptoms<br />
reduced<br />
Continue for two more<br />
weeks and then stop<br />
Signs and symptoms<br />
unchanged.<br />
Stop<br />
antimicrobials<br />
Reassess patient<br />
Seek advice from<br />
specialist nurse if<br />
required<br />
Wounds that respond to silver but deteriorate once silver is stopped<br />
should be treated with Cutimed Sorbact providing exudate is moderate.<br />
Please seek tissue viability support for MRSA infected wounds with low<br />
exudate.